AIM
Aigen Investment Management’s Charles River Laboratories CRL Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,536
| Closed | -$231K | – | 839 |
|
|
2025
Q1 | $231K | Buy |
+1,536
| New | +$231K | 0.04% | 589 |
|
|
2024
Q3 | – | Sell |
-1,445
| Closed | -$299K | – | 780 |
|
|
2024
Q2 | $299K | Buy |
+1,445
| New | +$299K | 0.06% | 470 |
|
|
2022
Q2 | – | Sell |
-4,011
| Closed | -$1.14M | – | 564 |
|
|
2022
Q1 | $1.14M | Buy |
4,011
+1,987
| +98% | +$564K | 0.2% | 140 |
|
|
2021
Q4 | $733K | Buy |
+2,024
| New | +$733K | 0.05% | 507 |
|
|
2020
Q2 | – | Sell |
-137
| Closed | -$17K | – | 905 |
|
|
2020
Q1 | $17K | Buy |
+137
| New | +$17K | ﹤0.01% | 1103 |
|